Linagliptin Impurity R is a structurally related byproduct arising from the synthetic pathway of linagliptin, characterized by a substituted pyrazine core linked to a tetrahydro-1,2,3-triazine moiety. Its molecular architecture features a 4-hydroxyphenyl ring appended to a piperazine scaffold, with a key distinction being the absence of the terminal carboxylic acid group present in the parent compound. This impurity retains the chiral centers at positions 3R,5S,6S, and 7R, but exhibits a truncated side chain, rendering it a critical intermediate degradation product. It serves as a reference standard for HPLC-based quantification of process-related impurities in linagliptin drug substance analysis.
On Request